Clinical Trials › NCT05688436
Recruiting
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Sponsored by Biogen
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 1178
Target enrollment
1
U.S. states
Sep 2021
Start date
Jan 2031
Expected completion
Interventions / Treatments
Diroximel FumarateAlemtuzumabFingolimodGlatiramer acetateInterferon betaNatalizumabOcrelizumabOfatumumabOzanimodPeginterferon beta-1aPonesimodSiponimod
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Minnesota1 site
Eden Prairie
MS centers in Minnesota
Compare treatment centers near a trial site by center type, providers and trials.
View Minnesota centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.